協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/06/23 | 3,850 | 3,935 | 3,850 | 3,890 | +25 | +0.6% | 771,200 |
| 2021/06/22 | 3,805 | 3,870 | 3,790 | 3,865 | +85 | +2.2% | 902,400 |
| 2021/06/21 | 3,790 | 3,820 | 3,720 | 3,780 | ±0 | ±0% | 1,305,500 |
| 2021/06/18 | 3,795 | 3,820 | 3,755 | 3,780 | +20 | +0.5% | 994,300 |
| 2021/06/17 | 3,850 | 3,865 | 3,735 | 3,760 | -70 | -1.8% | 571,000 |
| 2021/06/16 | 3,830 | 3,845 | 3,790 | 3,830 | +55 | +1.5% | 696,100 |
| 2021/06/15 | 3,740 | 3,810 | 3,735 | 3,775 | +10 | +0.3% | 715,100 |
| 2021/06/14 | 3,765 | 3,775 | 3,700 | 3,765 | +60 | +1.6% | 705,800 |
| 2021/06/11 | 3,670 | 3,715 | 3,640 | 3,705 | +35 | +1% | 928,600 |
| 2021/06/10 | 3,660 | 3,695 | 3,640 | 3,670 | +30 | +0.8% | 600,500 |
| 2021/06/09 | 3,605 | 3,660 | 3,590 | 3,640 | ±0 | ±0% | 787,100 |
| 2021/06/08 | 3,670 | 3,690 | 3,620 | 3,640 | +40 | +1.1% | 890,900 |
| 2021/06/07 | 3,600 | 3,620 | 3,545 | 3,600 | -5 | -0.1% | 660,000 |
| 2021/06/04 | 3,590 | 3,640 | 3,585 | 3,605 | -10 | -0.3% | 762,100 |
| 2021/06/03 | 3,560 | 3,655 | 3,545 | 3,615 | +55 | +1.5% | 1,032,600 |
| 2021/06/02 | 3,435 | 3,620 | 3,415 | 3,560 | +265 | +8% | 2,042,100 |
| 2021/06/01 | 3,320 | 3,330 | 3,270 | 3,295 | -15 | -0.5% | 491,800 |
| 2021/05/31 | 3,330 | 3,375 | 3,305 | 3,310 | -45 | -1.3% | 474,600 |
| 2021/05/28 | 3,360 | 3,375 | 3,320 | 3,355 | +45 | +1.4% | 832,500 |
| 2021/05/27 | 3,375 | 3,385 | 3,285 | 3,310 | -75 | -2.2% | 2,133,700 |
| 2021/05/26 | 3,360 | 3,390 | 3,345 | 3,385 | +25 | +0.7% | 618,300 |
| 2021/05/25 | 3,350 | 3,365 | 3,335 | 3,360 | +10 | +0.3% | 464,800 |
| 2021/05/24 | 3,335 | 3,370 | 3,320 | 3,350 | -5 | -0.1% | 421,400 |
| 2021/05/21 | 3,355 | 3,375 | 3,325 | 3,355 | +70 | +2.1% | 597,300 |
| 2021/05/20 | 3,310 | 3,330 | 3,250 | 3,285 | -75 | -2.2% | 703,700 |
| 2021/05/19 | 3,375 | 3,420 | 3,345 | 3,360 | -65 | -1.9% | 872,300 |
| 2021/05/18 | 3,355 | 3,470 | 3,340 | 3,425 | +90 | +2.7% | 1,113,500 |
| 2021/05/17 | 3,290 | 3,375 | 3,290 | 3,335 | +55 | +1.7% | 649,700 |
| 2021/05/14 | 3,205 | 3,305 | 3,185 | 3,280 | +70 | +2.2% | 925,300 |
| 2021/05/13 | 3,260 | 3,260 | 3,205 | 3,210 | -35 | -1.1% | 622,400 |
| 2021/05/12 | 3,285 | 3,335 | 3,225 | 3,245 | -75 | -2.3% | 1,151,200 |
| 2021/05/11 | 3,400 | 3,400 | 3,295 | 3,320 | -55 | -1.6% | 749,600 |
| 2021/05/10 | 3,365 | 3,435 | 3,335 | 3,375 | +25 | +0.7% | 973,000 |
| 2021/05/07 | 3,485 | 3,495 | 3,335 | 3,350 | -125 | -3.6% | 1,654,500 |
| 2021/05/06 | 3,420 | 3,490 | 3,395 | 3,475 | +155 | +4.7% | 1,711,600 |
| 2021/04/30 | 3,300 | 3,375 | 3,295 | 3,320 | +30 | +0.9% | 1,122,500 |
| 2021/04/28 | 3,310 | 3,330 | 3,280 | 3,290 | ±0 | ±0% | 731,600 |
| 2021/04/27 | 3,315 | 3,325 | 3,250 | 3,290 | -30 | -0.9% | 701,900 |
| 2021/04/26 | 3,310 | 3,365 | 3,290 | 3,320 | -10 | -0.3% | 733,100 |
| 2021/04/23 | 3,340 | 3,375 | 3,220 | 3,330 | -10 | -0.3% | 742,100 |
| 2021/04/22 | 3,275 | 3,345 | 3,275 | 3,340 | +110 | +3.4% | 630,300 |
| 2021/04/21 | 3,255 | 3,300 | 3,220 | 3,230 | -35 | -1.1% | 801,300 |
| 2021/04/20 | 3,355 | 3,355 | 3,250 | 3,265 | -90 | -2.7% | 805,700 |
| 2021/04/19 | 3,315 | 3,380 | 3,290 | 3,355 | +55 | +1.7% | 1,010,300 |
| 2021/04/16 | 3,295 | 3,320 | 3,280 | 3,300 | +15 | +0.5% | 590,200 |
| 2021/04/15 | 3,310 | 3,325 | 3,260 | 3,285 | -20 | -0.6% | 388,000 |
| 2021/04/14 | 3,290 | 3,315 | 3,265 | 3,305 | -5 | -0.2% | 513,200 |
| 2021/04/13 | 3,290 | 3,340 | 3,285 | 3,310 | +35 | +1.1% | 514,100 |
| 2021/04/12 | 3,290 | 3,305 | 3,250 | 3,275 | -5 | -0.2% | 449,600 |
| 2021/04/09 | 3,315 | 3,365 | 3,280 | 3,280 | -5 | -0.2% | 1,117,500 |
951～
1000
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
